Tardive dyskinesia after long-term veralipride treatment [2]

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 17, Issue 2, 2005, Pages 252-253

  Raja, Michele ^a   Azzoni, Antonella ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOMPERIDONE; METOCLOPRAMIDE; OLANZAPINE; VALPROIC ACID; VERALIPRIDE; DRUG DERIVATIVE; SULPIRIDE;

CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFECT; DRUG MECHANISM; EXTRAPYRAMIDAL SYMPTOM; FOLLOW UP; HUMAN; LETTER; LONG TERM CARE; MENOPAUSAL SYNDROME; PARKINSONISM; PRIORITY JOURNAL; TARDIVE DYSKINESIA; TREATMENT OUTCOME; AGED; CASE REPORT; DYSKINESIA; FEMALE; PSYCHOSIS;

AGED; AGED, 80 AND OVER; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; PSYCHOTIC DISORDERS; SULPIRIDE;

EID: 20544472171     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.17.2.252-a     Document Type: Letter

References (7)

1. David A, Don R, Tajchner G, Weissglas L: Veralipride: alternative antidopaminergic treatment for menopausal symptoms. Am J Obstet Gynecol 1988; 158:1107-1115
2. Brient-Clabaux J: Agreal: its acceptability: review of the literature. Rev Fr Gynecol Obstet 1985; 80:167-170
3. Masmoudi K, Decocq G, Chetaille E, et al: Extrapyramidal disorders induced by veralipride (agreal): apropos of 5 cases. Therapie 1995; 50:451-454
4. Laplane D, Dougados M, Macron JM: Dyskinesias due to veralipride. Nouv Presse Med 1982; 11:2015
5. Destee A, Warot P: Dyskinesia due to veralipride. Presse Med 1983; 12:1018
6. Gabellini AS, Pezzoli A, De Massis P, Sacquegna T: Veralipride-induced tardive dystonia in a patient with bipolar psychosis. It J Neurol Sci 1992; 13:621-623
7. Marta-Moreno E, Gracia-Naya M, Marzo-Sola ME: Respiratory dyskinesia induced by veralipride. Rev Neurol 1997; 25:245-247